{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:06:19Z","timestamp":1761239179995},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Peking University International Hospital Research Funds","award":["YN2020QN01","YN2020ZD03"],"award-info":[{"award-number":["YN2020QN01","YN2020ZD03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcoidosis is a multisystemic inflammatory disease, characterized by the presence of non-caseating, epithelioid granulomas. Glomerular disease in patients with sarcoidosis is rare and membranous nephropathy (MN) is cited as the most common. The association between the two diseases remained unclear. This article reported a case of co-occurrence of sarcoidosis and anti-PLA2R-associated MN, to provide a possible relationship between these two entities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 61-year-old Chinese Han woman with a history of sarcoidosis was admitted to our hospital for nephrotic syndrome. Her sarcoidosis was diagnosed according to the adenopathy observed on the computed tomography scan and the biopsy of lymph nodes. The MN presented with nephrotic syndrome with a PLA2R antibody titer of 357RU\/ml, and the final diagnosis was based on a renal biopsy. The patient\u2019s sarcoidosis was remitted after treatment with prednisone. One year later MN was diagnosed, and she was treated with prednisone combined with calcineurin inhibitors, based on a full dose of renin-angiotensin system (RAS) inhibitor. The patient\u2019s sarcoidosis had been in remission while the MN was recurrent, and her renal function deteriorated to end-stage renal disease 6 years later due to discontinuation of immunosuppression. A genetic test led to the identification of the HLA-DRB1*0301 and HLA-DRB1*150 genes associated with both sarcoidosis and MN, which provides a new possible explanation of the co-occurrence of these two diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case suggested for the first time a potential genetic connection between idiopathic MN and sarcoidosis which needs further studies in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03649-0","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:33:17Z","timestamp":1719505997000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The co-occurrence of sarcoidosis and anti-PLA2R-associated membranous nephropathy in a patient with underlying genetic susceptibility"],"prefix":"10.1186","volume":"25","author":[{"given":"Ying","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"21","key":"3649_CR1","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"3649_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.ki.5001512","volume":"70","author":"R Rajakariar","year":"2006","unstructured":"Rajakariar R, Sharples EJ, Raftery MJ, Sheaff M, Yaqoob MM. Sarcoid tubulo-interstitial nephritis: long-term outcome and response to corticosteroid therapy. Kidney Int. 2006;70(1):165\u20139.","journal-title":"Kidney Int"},{"key":"3649_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-2-46","volume":"2","author":"H Nunes","year":"2007","unstructured":"Nunes H, Bouvry D, Soler P, Valeyre D. Sarcoidosis Orphanet J Rare Dis. 2007;2:46.","journal-title":"Sarcoidosis Orphanet J Rare Dis"},{"issue":"5","key":"3649_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.ajkd.2006.07.022","volume":"48","author":"AR Berliner","year":"2006","unstructured":"Berliner AR, Haas M, Choi MJ. Sarcoidosis: the nephrologist\u2019s perspective. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2006;48(5):856\u201370.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"key":"3649_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1750-1172-8-65","volume":"8","author":"T Stehl\u00e9","year":"2013","unstructured":"Stehl\u00e9 T, Joly D, Vanhille P, Boffa JJ, R\u00e9my P, Mesnard L, et al. Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study. Orphanet J Rare Dis. 2013;8:65.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3649_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG. Primary Membranous Nephropathy. Clin J Am Soc Nephrology: CJASN. 2017;12(6):983\u201397.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"1","key":"3649_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"3649_CR8","doi-asserted-by":"publisher","first-page":"143274","DOI":"10.1155\/2014\/143274","volume":"2014","author":"A Behnert","year":"2014","unstructured":"Behnert A, Schiffer M, M\u00fcller-Deile J, Beck LH Jr., Mahler M, Fritzler MJ. Antiphospholipase A\u2082 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res. 2014;2014:143274.","journal-title":"J Immunol Res"},{"issue":"6","key":"3649_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH Jr., Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrology: JASN. 2011;22(6):1137\u201343.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"3649_CR10","first-page":"1047","volume":"30","author":"T Stehl\u00e9","year":"2015","unstructured":"Stehl\u00e9 T, Audard V, Ronco P, Debiec H. Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2015;30(6):1047\u201350.","journal-title":"Eur Ren Association"},{"issue":"5","key":"3649_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1681\/ASN.2016020114","volume":"28","author":"Z Cui","year":"2017","unstructured":"Cui Z, Xie LJ, Chen FJ, Pei ZY, Zhang LJ, Qu Z, et al. MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy. J Am Soc Nephrology: JASN. 2017;28(5):1651\u201364.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"1","key":"3649_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.humimm.2011.10.016","volume":"73","author":"A Wennerstr\u00f6m","year":"2012","unstructured":"Wennerstr\u00f6m A, Pietinalho A, Vauhkonen H, Lahtela L, Palikhe A, Hedman J, et al. HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis. Hum Immunol. 2012;73(1):93\u2013100.","journal-title":"Hum Immunol"},{"issue":"4","key":"3649_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00281-014-0423-y","volume":"36","author":"H Debiec","year":"2014","unstructured":"Debiec H, Ronco P. Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol. 2014;36(4):381\u201397.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"3649_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1445-5994.1978.tb04915.x","volume":"8","author":"AF Mariani","year":"1978","unstructured":"Mariani AF, Clifton S, Davies DJ, Dawborn JK, Fitzgerald JE, Ihle BU, et al. Membranous glomerulonephritis associated with sarcoidosis. Aust N Z J Med. 1978;8(4):420\u20135.","journal-title":"Aust N Z J Med"},{"issue":"10","key":"3649_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/archinte.1979.03630470091029","volume":"139","author":"TK Taylor","year":"1979","unstructured":"Taylor TK, Senekjian HO, Knight TF, Gy\u00f6rkey F, Weinman EJ. Membranous nephropathy with epithelial crescents in a patient with pulmonary sarcoidosis. Arch Intern Med. 1979;139(10):1183\u20135.","journal-title":"Arch Intern Med"},{"issue":"1","key":"3649_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000185597","volume":"52","author":"B Jones","year":"1989","unstructured":"Jones B, Fowler J. Membranous nephropathy associated with sarcoidosis. Response to prednisolone. Nephron. 1989;52(1):101\u20132.","journal-title":"Nephron"},{"issue":"4","key":"3649_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000187864","volume":"66","author":"IH Khan","year":"1994","unstructured":"Khan IH, Simpson JG, Catto GR, MacLeod AM. Membranous nephropathy and granulomatous interstitial nephritis in sarcoidosis. Nephron. 1994;66(4):459\u201361.","journal-title":"Nephron"},{"issue":"11","key":"3649_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2169\/internalmedicine.38.882","volume":"38","author":"T Toda","year":"1999","unstructured":"Toda T, Kimoto S, Nishio Y, Ehara T, Sasaki S. Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis. Intern Med (Tokyo Japan). 1999;38(11):882\u20136.","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"5","key":"3649_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s004670050637","volume":"13","author":"C Dimitriades","year":"1999","unstructured":"Dimitriades C, Shetty AK, Vehaskari M, Craver RD, Gedalia A. Membranous nephropathy associated with childhood sarcoidosis. Pediatr Nephrol. 1999;13(5):444\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3649_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.ajkd.2010.09.015","volume":"57","author":"M Knehtl","year":"2011","unstructured":"Knehtl M, Debiec H, Kamgang P, Callard P, Cadranel J, Ronco P, et al. A case of phospholipase A\u2082 receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2011;57(1):140\u20133.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"6","key":"3649_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.ekir.2023.03.019","volume":"8","author":"D Zubidat","year":"2023","unstructured":"Zubidat D, Madden B, Kudose S, Nasr SH, Nardelli L, Fervenza FC, et al. Heterogeneity of Target antigens in Sarcoidosis-Associated Membranous Nephropathy. Kidney Int Rep. 2023;8(6):1213\u20139.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"3649_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2018.06.005","volume":"94","author":"HY Wang","year":"2018","unstructured":"Wang HY, Cui Z, Xie LJ, Zhang LJ, Pei ZY, Chen FJ, et al. HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy. Kidney Int. 2018;94(5):974\u201382.","journal-title":"Kidney Int"},{"issue":"12","key":"3649_CR23","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1681\/ASN.2016010093","volume":"27","author":"X Xu","year":"2016","unstructured":"Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, et al. Long-term exposure to Air Pollution and increased risk of Membranous Nephropathy in China. J Am Soc Nephrology: JASN. 2016;27(12):3739\u201346.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"5","key":"3649_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1183\/09031936.00197808","volume":"35","author":"U Deubelbeiss","year":"2010","unstructured":"Deubelbeiss U, Gemperli A, Schindler C, Baty F, Brutsche MH. Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur Respir J. 2010;35(5):1088\u201397.","journal-title":"Eur Respir J"},{"issue":"15","key":"3649_CR25","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.1074\/jbc.270.15.8963","volume":"270","author":"P Ancian","year":"1995","unstructured":"Ancian P, Lambeau G, Matt\u00e9i MG, Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem. 1995;270(15):8963\u201370.","journal-title":"J Biol Chem"},{"issue":"4s","key":"3649_CR26","first-page":"S1","volume":"100","author":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","year":"2021","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4s):S1\u2013276.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03649-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:40:30Z","timestamp":1719506430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03649-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3649"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03649-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}